Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells
S. F. Paul Man, Alsya J. Affandi, Hendrik J. Brink, John L. van Hamme et autres
0 citationsJournal of Virology
Hendrik J. Brink
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
8Publications signalées
95Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Immunotherapy and Immune ResponsesMonoclonal and Polyclonal Antibodies ResearchUbiquitin and proteasome pathways14-3-3 protein interactionsHIV Research and Treatment
Publications récentes
Differential capacity of CD169- and CLEC9A-specific nanobody liposomes to bind to human APCs and elicit T cell activation
Rianne G. Bouma, Hendrik J. Brink, Cris Mons, Joeke G. C. Stolwijk et autres
0 citationsSSRN Electronic Journal
Development of a Versatile Cancer Vaccine Format Targeting Antigen-Presenting Cells Using Proximity-Based Sortase A-Mediated Ligation of T-Cell Epitopes
Aru Z. Wang, Hendrik J. Brink, Rianne G. Bouma, Alsya J. Affandi et autres
3 citationsBioconjugate Chemistry
Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity
Rianne G. Bouma, Maarten K. Nijen Twilhaar, Hendrik J. Brink, Alsya J. Affandi et autres
14 citationsInternational Journal of Pharmaceutics
A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P 1 signaling axis
Nick D. Bergkamp, Jeffrey R. van Senten, Hendrik J. Brink, Maarten P. Bebelman et autres
18 citationsScience Signaling
Fusicoccin-A Targets Cancerous Inhibitor of Protein Phosphatase 2A by Stabilizing a C-Terminal Interaction with 14-3-3
Hendrik J. Brink, Jeffrey R. van Senten, Ingrid J. de Vries-van Leeuwen, Daniel Da Costa Pereira et autres
13 citationsACS Chemical Biology
Fragment Screening Yields a Small‐Molecule Stabilizer of 14‐3‐3 Dimers That Modulates Client Protein Interactions
Hendrik J. Brink, Rick Riemens, Stephanie Thee, Berend Beishuizen et autres
14 citationsChemBioChem
CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome
Raymond H. de Wit, Raimond Heukers, Hendrik J. Brink, Angela Arsova et autres
33 citationsJournal of Pharmacology and Experimental Therapeutics
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.